Soroti, Uganda | URN | Soroti City authorities have pledged to intensify HIV testing and prevention after the city’s HIV prevalence rose from 11.6 percent to 12.4 percent, nearly three times Uganda’s reported national prevalence of 4.7 percent. The Uganda AIDS Commission (UAC) says the increase requires locally targeted interventions …
Read More »Africa is building drug factories; Now it needs enough buyers
About 70% to 80% of medicines consumed in Africa are imported, according to the Access to Medicine Foundation ANALYSIS | PATRICIA AKANKWATSA | Africa is pouring money into pharmaceutical manufacturing as governments seek to reduce dependence on imported medicines. The bigger challenge may be finding enough buyers to keep …
Read More »African scientists want governments to take charge of HIV cure research
Kampala, Uganda | URN | African scientists are urging governments across the continent to take greater ownership of HIV cure research, saying Africa must move beyond serving as a testing ground for scientific breakthroughs and become a global leader in developing an HIV cure. The call was made during the 2026 …
Read More »STUDY: HIV injectable drug offers pregnant, lactating mothers 100% protection
SPECIAL REPORT | URN | A sub-study of the landmark clinical trial evaluating the safety and efficacy of the twice-yearly injectable HIV prevention drug, Lenacapavir, has found that it provides 100 percent protection against HIV infection among pregnant and breastfeeding women using it as pre-exposure prophylaxis (PrEP). The Phase 3 …
Read More »Experts urge caution over HIV prevention injection
Kampala, Uganda | URN | Experts have urged those who already received their first injection of the twice-yearly HIV preventing drug Lenacapavir to consider using combination prevention options, warning that the game changer injection is not a vaccine. The initial recipients of the drug that has since had a lot …
Read More »Quality Chemicals joins global push for new HIV prevention medicine
The pharmaceutical company is among a select group of manufacturers preparing to produce an experimental once-monthly pill aimed at expanding HIV prevention options Kampala, Uganda | THE INDEPENDENT | Uganda’s Quality Chemical Industries Ltd. (QCIL) has secured an early manufacturing licence from Merck & Co. for an experimental …
Read More »HIV science races ahead as funding crisis threatens to widen access gap
People living with HIV need new treatment options that offer flexibility, and a weekly pill could broaden the choices available Kampala, Uganda | PATRICIA AKANKWATSA | For more than two decades, scientific innovation and international financing have worked together to transform HIV from a deadly disease into a …
Read More »Scientists study yearly HIV prevention injection possibility
Kampala, Uganda | URN | Scientists are exploring the possibility of having the popular HIV prevention injection Lenacapavir in a formulation dispensed once a year. The drug, first approved in 2025 and whose uptake is reported to be high in Uganda as a twice-yearly Pre-Exposure Prophylaxis (PrEP), according to Senior …
Read More »HIV integration must not come at the cost of access, experts warn
According to the World Health Organization, the African region remains home to nearly two-thirds of all people living with HIV globally Kampala, Uganda | PATRICIA AKANKWATSA | As Uganda and other African countries seek to integrate HIV prevention into mainstream health systems, experts are warning that the shift …
Read More »HIV jab demand outstrips supply in African rollout
Uganda and Kenya are among nine African countries to have received initial doses of the HIV drug Nairobi, Kenya | AGENCIES | Demand for a twice-yearly HIV prevention injection is outpacing supply in parts of Africa, with distribution covering a fraction of estimated need and leaving behind vulnerable slum communities, according to health …
Read More »
The Independent Uganda: You get the Truth we Pay the Price